(1 - 15 from 17
)
Mequon firm seeks to put the brakes on cancer cells
archive.jsonline.com
Endece LLC is prepared to begin clinical trials next year on a compound that could potentially turn off any kind of cancer cell.
The Myelin Repair Foundation and ENDECE Neural Form ...www.newswire.ca › news-releases › the-myelin-repair-foundation-and-end...
www.newswire.ca
8 Feb · James Yarger, Ph.D., President of ENDECE Neural. "Unlike current MS therapies, which target immune response and inflammation to slow ...
sorted by relevance / date